| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | CFO
2 companies
Greenway Schond L. is a Chief Financial Officer at MNMD, with reported holdings spanning 2 companies. Recent filings cover 2 purchases and 6 sales. Those positions are worth an estimated $2.1M at current prices.
Greenway Schond L.'s largest disclosed position is in MNMD as Chief Financial Officer, worth about $2.1M. The recent filings there lean toward selling, a net 43,049 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 26, 2023 | Chief Financial Officer | Sell | 5,652 | $3.63 | $20,516.76 | -2.5% | - | - | ||
| Sep 25, 2023 | Chief Financial Officer | Sell | 5,762 | $3.58 | $20,608.88 | -2.5% | - | - | ||
| Aug 25, 2023 | Chief Financial Officer | Sell | 20,000 | $3.80 | $76,000.00 | -8.1% | - | - | ||
| Jun 27, 2023 | Chief Financial Officer | Sell | 11,635 | $3.20 | $37,194.47 | -4.5% | - | - | ||
| Dec 10, 2021 | AVTX Avalo Therapeutics, Inc. | CFO | Buy | 2,231 | $1.57 | $3,502.67 | +135.0% | -61.9% | -76.6% | |
| Jun 10, 2021 | AVTX Avalo Therapeutics, Inc. | CFO | Buy | 652 | $2.68 | $1,747.36 | +65.2% | -22.9% | -87.0% |